During the past decade, Texas Dermatology and Laser Specialists conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 24 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 17 clinical trials were completed. i.e. 94.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Dermatology and Laser Specialists" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Pfizer" with 9 trials sponsored, "Amgen" with 2 trials sponsored, "Cassiopea SpA" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Dermatology and Laser Specialists" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Accelovance" with 1 trials as a collaborator, "ClinDatrix, Inc." with 1 trials as a collaborator and "Clinical Trials of Texas, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Texas Dermatology and Laser Specialists" are "Atopic Dermatitis" (13 trials), "Psoriasis" (8 trials), "Acne Vulgaris" (3 trials), "Dermatitis, Atopic" (3 trials) and "Hyperhidrosis" (3 trials). Many other conditions were trialed in "Texas Dermatology and Laser Specialists" in a lesser frequency.

Most popular intervention types in "Texas Dermatology and Laser Specialists" are "Drug" (42 trials), "Biological" (5 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Lebrikizumab" (4 trials), "Baricitinib" (3 trials), "Vehicle" (3 trials) and "CB-03-01 cream, 1%" (2 trials). Other intervention names were less common.

The vast majority of trials in "Texas Dermatology and Laser Specialists" are 48 trials for "All" genders.

Currently, there are NaN active trials in "Texas Dermatology and Laser Specialists". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Texas Dermatology and Laser Specialists, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Dermatology and Laser Specialists, 3 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".